RP
Recursion Pharmaceuticals Inc
🇺🇸XNAS.RXRXUnited StatesHealthcare
$3.26USDup +0.02 (+0.62%)OpenDelayed5:40 PM
Price$3.26+0.02 (+0.62%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US75629V1044
- CUSIP
- 75629V104
Company
- Employees
- 600
- Headquarters
- Salt Lake City, United States
- Website
- https://www.recursion.com
- CEO
- Dr. Najat Khan Ph.D.
Market
- Shares outstanding
- 535.3M
- Market cap
- $1.75B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $1.73B
- EPS LTM
- -$0.97
- P/E LTM
- -3.35calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $54.86M-14.88%down year on year
- Net income
- -$518.89M+20.04%up year on year
- Gross margin
- -46.66%-1,141.44%down year on year
- Free cash flow
- -$354.27M+10.14%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.